nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—Constipation—Estropipate—osteoporosis	0.00112	0.00222	CcSEcCtD
Bepridil—Dyspepsia—Raloxifene—osteoporosis	0.00111	0.00222	CcSEcCtD
Bepridil—Loss of consciousness—Risedronate—osteoporosis	0.00111	0.00221	CcSEcCtD
Bepridil—Insomnia—Calcitriol—osteoporosis	0.00111	0.00221	CcSEcCtD
Bepridil—Cough—Risedronate—osteoporosis	0.0011	0.0022	CcSEcCtD
Bepridil—Dyspepsia—Ibandronate—osteoporosis	0.0011	0.00219	CcSEcCtD
Bepridil—Anxiety—Ethinyl Estradiol—osteoporosis	0.0011	0.00219	CcSEcCtD
Bepridil—Pain—Alendronate—osteoporosis	0.0011	0.00219	CcSEcCtD
Bepridil—Constipation—Alendronate—osteoporosis	0.0011	0.00219	CcSEcCtD
Bepridil—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00109	0.00217	CcSEcCtD
Bepridil—Hypertension—Risedronate—osteoporosis	0.00109	0.00217	CcSEcCtD
Bepridil—Somnolence—Calcitriol—osteoporosis	0.00109	0.00217	CcSEcCtD
Bepridil—Decreased appetite—Ibandronate—osteoporosis	0.00109	0.00217	CcSEcCtD
Bepridil—Arrhythmia—Conjugated Estrogens—osteoporosis	0.00109	0.00216	CcSEcCtD
Bepridil—Pain—Raloxifene—osteoporosis	0.00108	0.00215	CcSEcCtD
Bepridil—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00108	0.00215	CcSEcCtD
Bepridil—Depression—Estradiol—osteoporosis	0.00108	0.00215	CcSEcCtD
Bepridil—Syncope—Pamidronate—osteoporosis	0.00108	0.00215	CcSEcCtD
Bepridil—Myalgia—Risedronate—osteoporosis	0.00108	0.00214	CcSEcCtD
Bepridil—Anxiety—Risedronate—osteoporosis	0.00107	0.00214	CcSEcCtD
Bepridil—Pain—Ibandronate—osteoporosis	0.00107	0.00213	CcSEcCtD
Bepridil—Constipation—Ibandronate—osteoporosis	0.00107	0.00213	CcSEcCtD
Bepridil—Gastrointestinal pain—Estropipate—osteoporosis	0.00107	0.00213	CcSEcCtD
Bepridil—Decreased appetite—Calcitriol—osteoporosis	0.00107	0.00212	CcSEcCtD
Bepridil—Oedema—Ethinyl Estradiol—osteoporosis	0.00106	0.00211	CcSEcCtD
Bepridil—Loss of consciousness—Pamidronate—osteoporosis	0.00106	0.0021	CcSEcCtD
Bepridil—Dry mouth—Risedronate—osteoporosis	0.00105	0.0021	CcSEcCtD
Bepridil—Gastrointestinal pain—Alendronate—osteoporosis	0.00105	0.00209	CcSEcCtD
Bepridil—Cough—Pamidronate—osteoporosis	0.00105	0.00209	CcSEcCtD
Bepridil—Constipation—Calcitriol—osteoporosis	0.00105	0.00209	CcSEcCtD
Bepridil—Pain—Calcitriol—osteoporosis	0.00105	0.00209	CcSEcCtD
Bepridil—Flatulence—Conjugated Estrogens—osteoporosis	0.00104	0.00207	CcSEcCtD
Bepridil—Hypertension—Pamidronate—osteoporosis	0.00104	0.00207	CcSEcCtD
Bepridil—Tension—Conjugated Estrogens—osteoporosis	0.00104	0.00207	CcSEcCtD
Bepridil—Vision blurred—Zoledronate—osteoporosis	0.00104	0.00206	CcSEcCtD
Bepridil—Gastrointestinal pain—Raloxifene—osteoporosis	0.00104	0.00206	CcSEcCtD
Bepridil—Diarrhoea—Etidronic acid—osteoporosis	0.00103	0.00206	CcSEcCtD
Bepridil—Body temperature increased—Estropipate—osteoporosis	0.00103	0.00206	CcSEcCtD
Bepridil—Abdominal pain—Estropipate—osteoporosis	0.00103	0.00206	CcSEcCtD
Bepridil—Tremor—Zoledronate—osteoporosis	0.00103	0.00205	CcSEcCtD
Bepridil—Nervousness—Conjugated Estrogens—osteoporosis	0.00103	0.00204	CcSEcCtD
Bepridil—Gastrointestinal pain—Ibandronate—osteoporosis	0.00102	0.00204	CcSEcCtD
Bepridil—Myalgia—Pamidronate—osteoporosis	0.00102	0.00204	CcSEcCtD
Bepridil—Anxiety—Pamidronate—osteoporosis	0.00102	0.00203	CcSEcCtD
Bepridil—Body temperature increased—Alendronate—osteoporosis	0.00102	0.00202	CcSEcCtD
Bepridil—Abdominal pain—Alendronate—osteoporosis	0.00102	0.00202	CcSEcCtD
Bepridil—Shock—Risedronate—osteoporosis	0.00102	0.00202	CcSEcCtD
Bepridil—Gastrointestinal pain—Calcitriol—osteoporosis	0.001	0.002	CcSEcCtD
Bepridil—Abdominal pain—Raloxifene—osteoporosis	0.001	0.00199	CcSEcCtD
Bepridil—Body temperature increased—Raloxifene—osteoporosis	0.001	0.00199	CcSEcCtD
Bepridil—Vision blurred—Conjugated Estrogens—osteoporosis	0.000997	0.00198	CcSEcCtD
Bepridil—Abdominal pain—Ibandronate—osteoporosis	0.000991	0.00197	CcSEcCtD
Bepridil—Body temperature increased—Ibandronate—osteoporosis	0.000991	0.00197	CcSEcCtD
Bepridil—Vertigo—Zoledronate—osteoporosis	0.000987	0.00196	CcSEcCtD
Bepridil—Syncope—Zoledronate—osteoporosis	0.000986	0.00196	CcSEcCtD
Bepridil—Oedema—Pamidronate—osteoporosis	0.000982	0.00195	CcSEcCtD
Bepridil—Rhinitis—Estradiol—osteoporosis	0.000975	0.00194	CcSEcCtD
Bepridil—Palpitations—Zoledronate—osteoporosis	0.000971	0.00193	CcSEcCtD
Bepridil—Body temperature increased—Calcitriol—osteoporosis	0.00097	0.00193	CcSEcCtD
Bepridil—Abdominal pain—Calcitriol—osteoporosis	0.00097	0.00193	CcSEcCtD
Bepridil—Shock—Pamidronate—osteoporosis	0.000966	0.00192	CcSEcCtD
Bepridil—Loss of consciousness—Zoledronate—osteoporosis	0.000966	0.00192	CcSEcCtD
Bepridil—Pharyngitis—Estradiol—osteoporosis	0.000966	0.00192	CcSEcCtD
Bepridil—Cough—Zoledronate—osteoporosis	0.000959	0.00191	CcSEcCtD
Bepridil—Rash—Etidronic acid—osteoporosis	0.000953	0.0019	CcSEcCtD
Bepridil—Dermatitis—Etidronic acid—osteoporosis	0.000952	0.00189	CcSEcCtD
Bepridil—Vertigo—Conjugated Estrogens—osteoporosis	0.000951	0.00189	CcSEcCtD
Bepridil—Hyperhidrosis—Pamidronate—osteoporosis	0.000949	0.00189	CcSEcCtD
Bepridil—Syncope—Conjugated Estrogens—osteoporosis	0.000949	0.00189	CcSEcCtD
Bepridil—Hypertension—Zoledronate—osteoporosis	0.000949	0.00189	CcSEcCtD
Bepridil—Headache—Etidronic acid—osteoporosis	0.000946	0.00188	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000941	0.00187	CcSEcCtD
Bepridil—Asthenia—Estropipate—osteoporosis	0.000938	0.00187	CcSEcCtD
Bepridil—Anorexia—Pamidronate—osteoporosis	0.000936	0.00186	CcSEcCtD
Bepridil—Myalgia—Zoledronate—osteoporosis	0.000936	0.00186	CcSEcCtD
Bepridil—Palpitations—Conjugated Estrogens—osteoporosis	0.000935	0.00186	CcSEcCtD
Bepridil—Insomnia—Risedronate—osteoporosis	0.000934	0.00186	CcSEcCtD
Bepridil—Anxiety—Zoledronate—osteoporosis	0.000932	0.00185	CcSEcCtD
Bepridil—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00093	0.00185	CcSEcCtD
Bepridil—Paraesthesia—Risedronate—osteoporosis	0.000927	0.00185	CcSEcCtD
Bepridil—Asthenia—Alendronate—osteoporosis	0.000924	0.00184	CcSEcCtD
Bepridil—Cough—Conjugated Estrogens—osteoporosis	0.000923	0.00184	CcSEcCtD
Bepridil—Dyspnoea—Risedronate—osteoporosis	0.000921	0.00183	CcSEcCtD
Bepridil—Dry mouth—Zoledronate—osteoporosis	0.000915	0.00182	CcSEcCtD
Bepridil—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000915	0.00182	CcSEcCtD
Bepridil—Dyspepsia—Risedronate—osteoporosis	0.000909	0.00181	CcSEcCtD
Bepridil—Tinnitus—Estradiol—osteoporosis	0.000907	0.0018	CcSEcCtD
Bepridil—Constipation—Ethinyl Estradiol—osteoporosis	0.000906	0.0018	CcSEcCtD
Bepridil—Cardiac disorder—Estradiol—osteoporosis	0.000903	0.0018	CcSEcCtD
Bepridil—Myalgia—Conjugated Estrogens—osteoporosis	0.000901	0.00179	CcSEcCtD
Bepridil—Asthenia—Ibandronate—osteoporosis	0.000899	0.00179	CcSEcCtD
Bepridil—Anxiety—Conjugated Estrogens—osteoporosis	0.000898	0.00179	CcSEcCtD
Bepridil—Nausea—Etidronic acid—osteoporosis	0.000897	0.00179	CcSEcCtD
Bepridil—Oedema—Zoledronate—osteoporosis	0.000897	0.00178	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000895	0.00178	CcSEcCtD
Bepridil—Diarrhoea—Estropipate—osteoporosis	0.000894	0.00178	CcSEcCtD
Bepridil—Gastrointestinal disorder—Risedronate—osteoporosis	0.000892	0.00177	CcSEcCtD
Bepridil—Insomnia—Pamidronate—osteoporosis	0.000888	0.00177	CcSEcCtD
Bepridil—Constipation—Risedronate—osteoporosis	0.000883	0.00176	CcSEcCtD
Bepridil—Pain—Risedronate—osteoporosis	0.000883	0.00176	CcSEcCtD
Bepridil—Shock—Zoledronate—osteoporosis	0.000882	0.00176	CcSEcCtD
Bepridil—Paraesthesia—Pamidronate—osteoporosis	0.000882	0.00175	CcSEcCtD
Bepridil—Diarrhoea—Alendronate—osteoporosis	0.000881	0.00175	CcSEcCtD
Bepridil—Asthenia—Calcitriol—osteoporosis	0.00088	0.00175	CcSEcCtD
Bepridil—Dyspnoea—Pamidronate—osteoporosis	0.000875	0.00174	CcSEcCtD
Bepridil—Somnolence—Pamidronate—osteoporosis	0.000873	0.00174	CcSEcCtD
Bepridil—Hyperhidrosis—Zoledronate—osteoporosis	0.000867	0.00172	CcSEcCtD
Bepridil—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000866	0.00172	CcSEcCtD
Bepridil—Diarrhoea—Raloxifene—osteoporosis	0.000866	0.00172	CcSEcCtD
Bepridil—Dyspepsia—Pamidronate—osteoporosis	0.000864	0.00172	CcSEcCtD
Bepridil—Dizziness—Estropipate—osteoporosis	0.000864	0.00172	CcSEcCtD
Bepridil—Oedema—Conjugated Estrogens—osteoporosis	0.000864	0.00172	CcSEcCtD
Bepridil—Diarrhoea—Ibandronate—osteoporosis	0.000858	0.00171	CcSEcCtD
Bepridil—Anorexia—Zoledronate—osteoporosis	0.000855	0.0017	CcSEcCtD
Bepridil—Decreased appetite—Pamidronate—osteoporosis	0.000854	0.0017	CcSEcCtD
Bepridil—Dizziness—Alendronate—osteoporosis	0.000851	0.00169	CcSEcCtD
Bepridil—Shock—Conjugated Estrogens—osteoporosis	0.00085	0.00169	CcSEcCtD
Bepridil—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000848	0.00169	CcSEcCtD
Bepridil—Gastrointestinal pain—Risedronate—osteoporosis	0.000845	0.00168	CcSEcCtD
Bepridil—Constipation—Pamidronate—osteoporosis	0.00084	0.00167	CcSEcCtD
Bepridil—Pain—Pamidronate—osteoporosis	0.00084	0.00167	CcSEcCtD
Bepridil—Diarrhoea—Calcitriol—osteoporosis	0.000839	0.00167	CcSEcCtD
Bepridil—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000837	0.00167	CcSEcCtD
Bepridil—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000837	0.00167	CcSEcCtD
Bepridil—Dizziness—Raloxifene—osteoporosis	0.000837	0.00167	CcSEcCtD
Bepridil—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000835	0.00166	CcSEcCtD
Bepridil—Flatulence—Estradiol—osteoporosis	0.000835	0.00166	CcSEcCtD
Bepridil—Tension—Estradiol—osteoporosis	0.000831	0.00165	CcSEcCtD
Bepridil—Dizziness—Ibandronate—osteoporosis	0.000829	0.00165	CcSEcCtD
Bepridil—Rash—Estropipate—osteoporosis	0.000824	0.00164	CcSEcCtD
Bepridil—Dermatitis—Estropipate—osteoporosis	0.000823	0.00164	CcSEcCtD
Bepridil—Anorexia—Conjugated Estrogens—osteoporosis	0.000823	0.00164	CcSEcCtD
Bepridil—Nervousness—Estradiol—osteoporosis	0.000823	0.00164	CcSEcCtD
Bepridil—Headache—Estropipate—osteoporosis	0.000819	0.00163	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000817	0.00163	CcSEcCtD
Bepridil—Body temperature increased—Risedronate—osteoporosis	0.000817	0.00162	CcSEcCtD
Bepridil—Abdominal pain—Risedronate—osteoporosis	0.000817	0.00162	CcSEcCtD
Bepridil—Rash—Alendronate—osteoporosis	0.000812	0.00161	CcSEcCtD
Bepridil—Insomnia—Zoledronate—osteoporosis	0.000811	0.00161	CcSEcCtD
Bepridil—Dermatitis—Alendronate—osteoporosis	0.000811	0.00161	CcSEcCtD
Bepridil—Headache—Alendronate—osteoporosis	0.000806	0.0016	CcSEcCtD
Bepridil—Paraesthesia—Zoledronate—osteoporosis	0.000805	0.0016	CcSEcCtD
Bepridil—Gastrointestinal pain—Pamidronate—osteoporosis	0.000803	0.0016	CcSEcCtD
Bepridil—Dyspnoea—Zoledronate—osteoporosis	0.0008	0.00159	CcSEcCtD
Bepridil—Rash—Raloxifene—osteoporosis	0.000798	0.00159	CcSEcCtD
Bepridil—Dermatitis—Raloxifene—osteoporosis	0.000798	0.00159	CcSEcCtD
Bepridil—Somnolence—Zoledronate—osteoporosis	0.000797	0.00159	CcSEcCtD
Bepridil—Tremor—Estradiol—osteoporosis	0.000793	0.00158	CcSEcCtD
Bepridil—Headache—Raloxifene—osteoporosis	0.000793	0.00158	CcSEcCtD
Bepridil—Rash—Ibandronate—osteoporosis	0.00079	0.00157	CcSEcCtD
Bepridil—Dermatitis—Ibandronate—osteoporosis	0.00079	0.00157	CcSEcCtD
Bepridil—Dyspepsia—Zoledronate—osteoporosis	0.00079	0.00157	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000787	0.00157	CcSEcCtD
Bepridil—Headache—Ibandronate—osteoporosis	0.000785	0.00156	CcSEcCtD
Bepridil—Insomnia—Conjugated Estrogens—osteoporosis	0.000781	0.00155	CcSEcCtD
Bepridil—Decreased appetite—Zoledronate—osteoporosis	0.00078	0.00155	CcSEcCtD
Bepridil—Nausea—Estropipate—osteoporosis	0.000776	0.00154	CcSEcCtD
Bepridil—Abdominal pain—Pamidronate—osteoporosis	0.000776	0.00154	CcSEcCtD
Bepridil—Body temperature increased—Pamidronate—osteoporosis	0.000776	0.00154	CcSEcCtD
Bepridil—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000775	0.00154	CcSEcCtD
Bepridil—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000774	0.00154	CcSEcCtD
Bepridil—Rash—Calcitriol—osteoporosis	0.000774	0.00154	CcSEcCtD
Bepridil—Dermatitis—Calcitriol—osteoporosis	0.000773	0.00154	CcSEcCtD
Bepridil—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00077	0.00153	CcSEcCtD
Bepridil—Headache—Calcitriol—osteoporosis	0.000769	0.00153	CcSEcCtD
Bepridil—Somnolence—Conjugated Estrogens—osteoporosis	0.000768	0.00153	CcSEcCtD
Bepridil—Constipation—Zoledronate—osteoporosis	0.000767	0.00153	CcSEcCtD
Bepridil—Pain—Zoledronate—osteoporosis	0.000767	0.00153	CcSEcCtD
Bepridil—Nausea—Alendronate—osteoporosis	0.000765	0.00152	CcSEcCtD
Bepridil—Vertigo—Estradiol—osteoporosis	0.000761	0.00151	CcSEcCtD
Bepridil—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00076	0.00151	CcSEcCtD
Bepridil—Asthenia—Ethinyl Estradiol—osteoporosis	0.00076	0.00151	CcSEcCtD
Bepridil—Syncope—Estradiol—osteoporosis	0.000759	0.00151	CcSEcCtD
Bepridil—Nausea—Raloxifene—osteoporosis	0.000752	0.0015	CcSEcCtD
Bepridil—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000751	0.00149	CcSEcCtD
Bepridil—Palpitations—Estradiol—osteoporosis	0.000748	0.00149	CcSEcCtD
Bepridil—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000746	0.00148	CcSEcCtD
Bepridil—Nausea—Ibandronate—osteoporosis	0.000744	0.00148	CcSEcCtD
Bepridil—Loss of consciousness—Estradiol—osteoporosis	0.000744	0.00148	CcSEcCtD
Bepridil—Asthenia—Risedronate—osteoporosis	0.000741	0.00147	CcSEcCtD
Bepridil—Cough—Estradiol—osteoporosis	0.000739	0.00147	CcSEcCtD
Bepridil—Constipation—Conjugated Estrogens—osteoporosis	0.000739	0.00147	CcSEcCtD
Bepridil—Pain—Conjugated Estrogens—osteoporosis	0.000739	0.00147	CcSEcCtD
Bepridil—Gastrointestinal pain—Zoledronate—osteoporosis	0.000733	0.00146	CcSEcCtD
Bepridil—Hypertension—Estradiol—osteoporosis	0.000731	0.00145	CcSEcCtD
Bepridil—Nausea—Calcitriol—osteoporosis	0.000729	0.00145	CcSEcCtD
Bepridil—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000725	0.00144	CcSEcCtD
Bepridil—Myalgia—Estradiol—osteoporosis	0.000721	0.00143	CcSEcCtD
Bepridil—Anxiety—Estradiol—osteoporosis	0.000719	0.00143	CcSEcCtD
Bepridil—Abdominal pain—Zoledronate—osteoporosis	0.000709	0.00141	CcSEcCtD
Bepridil—Body temperature increased—Zoledronate—osteoporosis	0.000709	0.00141	CcSEcCtD
Bepridil—Diarrhoea—Risedronate—osteoporosis	0.000707	0.00141	CcSEcCtD
Bepridil—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000706	0.0014	CcSEcCtD
Bepridil—Dry mouth—Estradiol—osteoporosis	0.000705	0.0014	CcSEcCtD
Bepridil—Asthenia—Pamidronate—osteoporosis	0.000704	0.0014	CcSEcCtD
Bepridil—Dizziness—Ethinyl Estradiol—osteoporosis	0.000701	0.00139	CcSEcCtD
Bepridil—Oedema—Estradiol—osteoporosis	0.000691	0.00138	CcSEcCtD
Bepridil—Dizziness—Risedronate—osteoporosis	0.000683	0.00136	CcSEcCtD
Bepridil—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000683	0.00136	CcSEcCtD
Bepridil—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000683	0.00136	CcSEcCtD
Bepridil—Shock—Estradiol—osteoporosis	0.00068	0.00135	CcSEcCtD
Bepridil—Diarrhoea—Pamidronate—osteoporosis	0.000672	0.00134	CcSEcCtD
Bepridil—Hyperhidrosis—Estradiol—osteoporosis	0.000668	0.00133	CcSEcCtD
Bepridil—Rash—Ethinyl Estradiol—osteoporosis	0.000668	0.00133	CcSEcCtD
Bepridil—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000667	0.00133	CcSEcCtD
Bepridil—Headache—Ethinyl Estradiol—osteoporosis	0.000664	0.00132	CcSEcCtD
Bepridil—Rash—Risedronate—osteoporosis	0.000651	0.0013	CcSEcCtD
Bepridil—Dermatitis—Risedronate—osteoporosis	0.000651	0.00129	CcSEcCtD
Bepridil—Dizziness—Pamidronate—osteoporosis	0.000649	0.00129	CcSEcCtD
Bepridil—Headache—Risedronate—osteoporosis	0.000647	0.00129	CcSEcCtD
Bepridil—Asthenia—Zoledronate—osteoporosis	0.000644	0.00128	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Estradiol—osteoporosis	0.00063	0.00125	CcSEcCtD
Bepridil—Nausea—Ethinyl Estradiol—osteoporosis	0.000629	0.00125	CcSEcCtD
Bepridil—Insomnia—Estradiol—osteoporosis	0.000625	0.00124	CcSEcCtD
Bepridil—Paraesthesia—Estradiol—osteoporosis	0.000621	0.00123	CcSEcCtD
Bepridil—Asthenia—Conjugated Estrogens—osteoporosis	0.00062	0.00123	CcSEcCtD
Bepridil—Rash—Pamidronate—osteoporosis	0.000619	0.00123	CcSEcCtD
Bepridil—Dermatitis—Pamidronate—osteoporosis	0.000619	0.00123	CcSEcCtD
Bepridil—Dyspnoea—Estradiol—osteoporosis	0.000616	0.00123	CcSEcCtD
Bepridil—Headache—Pamidronate—osteoporosis	0.000615	0.00122	CcSEcCtD
Bepridil—Somnolence—Estradiol—osteoporosis	0.000614	0.00122	CcSEcCtD
Bepridil—Diarrhoea—Zoledronate—osteoporosis	0.000614	0.00122	CcSEcCtD
Bepridil—Nausea—Risedronate—osteoporosis	0.000614	0.00122	CcSEcCtD
Bepridil—Dyspepsia—Estradiol—osteoporosis	0.000608	0.00121	CcSEcCtD
Bepridil—Decreased appetite—Estradiol—osteoporosis	0.000601	0.0012	CcSEcCtD
Bepridil—Gastrointestinal disorder—Estradiol—osteoporosis	0.000597	0.00119	CcSEcCtD
Bepridil—Dizziness—Zoledronate—osteoporosis	0.000593	0.00118	CcSEcCtD
Bepridil—Constipation—Estradiol—osteoporosis	0.000591	0.00118	CcSEcCtD
Bepridil—Pain—Estradiol—osteoporosis	0.000591	0.00118	CcSEcCtD
Bepridil—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000591	0.00118	CcSEcCtD
Bepridil—Nausea—Pamidronate—osteoporosis	0.000583	0.00116	CcSEcCtD
Bepridil—Dizziness—Conjugated Estrogens—osteoporosis	0.000571	0.00114	CcSEcCtD
Bepridil—Rash—Zoledronate—osteoporosis	0.000566	0.00113	CcSEcCtD
Bepridil—Gastrointestinal pain—Estradiol—osteoporosis	0.000565	0.00112	CcSEcCtD
Bepridil—Dermatitis—Zoledronate—osteoporosis	0.000565	0.00112	CcSEcCtD
Bepridil—Headache—Zoledronate—osteoporosis	0.000562	0.00112	CcSEcCtD
Bepridil—Abdominal pain—Estradiol—osteoporosis	0.000546	0.00109	CcSEcCtD
Bepridil—Body temperature increased—Estradiol—osteoporosis	0.000546	0.00109	CcSEcCtD
Bepridil—Rash—Conjugated Estrogens—osteoporosis	0.000545	0.00108	CcSEcCtD
Bepridil—Dermatitis—Conjugated Estrogens—osteoporosis	0.000544	0.00108	CcSEcCtD
Bepridil—Headache—Conjugated Estrogens—osteoporosis	0.000541	0.00108	CcSEcCtD
Bepridil—Nausea—Zoledronate—osteoporosis	0.000533	0.00106	CcSEcCtD
Bepridil—Nausea—Conjugated Estrogens—osteoporosis	0.000513	0.00102	CcSEcCtD
Bepridil—Asthenia—Estradiol—osteoporosis	0.000496	0.000987	CcSEcCtD
Bepridil—Diarrhoea—Estradiol—osteoporosis	0.000473	0.000941	CcSEcCtD
Bepridil—Dizziness—Estradiol—osteoporosis	0.000457	0.000909	CcSEcCtD
Bepridil—Rash—Estradiol—osteoporosis	0.000436	0.000867	CcSEcCtD
Bepridil—Dermatitis—Estradiol—osteoporosis	0.000435	0.000866	CcSEcCtD
Bepridil—Headache—Estradiol—osteoporosis	0.000433	0.000861	CcSEcCtD
Bepridil—Nausea—Estradiol—osteoporosis	0.000411	0.000817	CcSEcCtD
Bepridil—ABCB1—Metabolism—ACP5—osteoporosis	3.81e-05	7.67e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—POMC—osteoporosis	3.77e-05	7.57e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—IRS1—osteoporosis	3.77e-05	7.57e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—IGF1—osteoporosis	3.75e-05	7.53e-05	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—IGF1—osteoporosis	3.75e-05	7.53e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—CALCA—osteoporosis	3.73e-05	7.49e-05	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—POMC—osteoporosis	3.7e-05	7.45e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CYP27A1—osteoporosis	3.69e-05	7.43e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—P4HB—osteoporosis	3.68e-05	7.39e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—IL6R—osteoporosis	3.67e-05	7.38e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—KL—osteoporosis	3.67e-05	7.37e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—IRS1—osteoporosis	3.64e-05	7.32e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—IRS1—osteoporosis	3.64e-05	7.32e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—IGF1—osteoporosis	3.62e-05	7.28e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—IRS1—osteoporosis	3.62e-05	7.27e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—CALCA—osteoporosis	3.6e-05	7.25e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—CALCA—osteoporosis	3.6e-05	7.25e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—ACP5—osteoporosis	3.59e-05	7.22e-05	CbGpPWpGaD
Bepridil—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.59e-05	7.22e-05	CbGpPWpGaD
Bepridil—CALM3—NGF signalling via TRKA from the plasma membrane—IL6—osteoporosis	3.59e-05	7.22e-05	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	3.58e-05	7.2e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PTH—osteoporosis	3.58e-05	7.19e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—IRS1—osteoporosis	3.58e-05	7.19e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—P4HB—osteoporosis	3.56e-05	7.15e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—P4HB—osteoporosis	3.56e-05	7.15e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—KL—osteoporosis	3.55e-05	7.13e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—KL—osteoporosis	3.55e-05	7.13e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—TPI1—osteoporosis	3.54e-05	7.13e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—IL6R—osteoporosis	3.54e-05	7.11e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—RAP1A—osteoporosis	3.52e-05	7.07e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—IRS1—osteoporosis	3.5e-05	7.03e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—IRS1—osteoporosis	3.5e-05	7.03e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CNR2—osteoporosis	3.49e-05	7.01e-05	CbGpPWpGaD
Bepridil—CALM1—NGF signalling via TRKA from the plasma membrane—IL6—osteoporosis	3.47e-05	6.99e-05	CbGpPWpGaD
Bepridil—CALM2—NGF signalling via TRKA from the plasma membrane—IL6—osteoporosis	3.47e-05	6.99e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PTH—osteoporosis	3.46e-05	6.96e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PTH—osteoporosis	3.46e-05	6.96e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—POMC—osteoporosis	3.44e-05	6.92e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NFATC1—osteoporosis	3.43e-05	6.9e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—IL6R—osteoporosis	3.42e-05	6.88e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—IL6R—osteoporosis	3.42e-05	6.88e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—DKK1—osteoporosis	3.4e-05	6.84e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—RAP1A—osteoporosis	3.4e-05	6.84e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—RAP1A—osteoporosis	3.4e-05	6.84e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—ENO1—osteoporosis	3.4e-05	6.83e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by Wnt—MYC—osteoporosis	3.38e-05	6.8e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—KL—osteoporosis	3.38e-05	6.8e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CNR2—osteoporosis	3.37e-05	6.78e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CNR2—osteoporosis	3.37e-05	6.78e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—IL6R—osteoporosis	3.36e-05	6.75e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PSMA2—osteoporosis	3.35e-05	6.73e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PSMA5—osteoporosis	3.35e-05	6.73e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—TPI1—osteoporosis	3.34e-05	6.72e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—P4HB—osteoporosis	3.33e-05	6.7e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NFATC1—osteoporosis	3.32e-05	6.67e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NFATC1—osteoporosis	3.32e-05	6.67e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—IGF1—osteoporosis	3.31e-05	6.66e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—DKK1—osteoporosis	3.29e-05	6.62e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—DKK1—osteoporosis	3.29e-05	6.62e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—ENO1—osteoporosis	3.29e-05	6.61e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—ENO1—osteoporosis	3.29e-05	6.61e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—WNT1—osteoporosis	3.28e-05	6.59e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by Wnt—MYC—osteoporosis	3.27e-05	6.58e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by Wnt—MYC—osteoporosis	3.27e-05	6.58e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—KL—osteoporosis	3.27e-05	6.58e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—KL—osteoporosis	3.27e-05	6.58e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GAPDH—osteoporosis	3.27e-05	6.58e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PSMA5—osteoporosis	3.24e-05	6.51e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PSMA2—osteoporosis	3.24e-05	6.51e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PSMA2—osteoporosis	3.24e-05	6.51e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PSMA5—osteoporosis	3.24e-05	6.51e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—FGA—osteoporosis	3.19e-05	6.41e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—RAP1A—osteoporosis	3.19e-05	6.41e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—WNT1—osteoporosis	3.17e-05	6.37e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—WNT1—osteoporosis	3.17e-05	6.37e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—ADCY5—osteoporosis	3.14e-05	6.32e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—P4HB—osteoporosis	3.14e-05	6.31e-05	CbGpPWpGaD
Bepridil—PDE1A—Disease—MYC—osteoporosis	3.11e-05	6.25e-05	CbGpPWpGaD
Bepridil—PDE1A—Disease—TGFB1—osteoporosis	3.1e-05	6.23e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—FGA—osteoporosis	3.08e-05	6.2e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—FGA—osteoporosis	3.08e-05	6.2e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GAPDH—osteoporosis	3.08e-05	6.2e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—ADCY5—osteoporosis	3.04e-05	6.11e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—ADCY5—osteoporosis	3.04e-05	6.11e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—RAP1A—osteoporosis	3e-05	6.04e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—BMP2—osteoporosis	2.96e-05	5.96e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PTHLH—osteoporosis	2.96e-05	5.96e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—FGB—osteoporosis	2.9e-05	5.83e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—AGER—osteoporosis	2.88e-05	5.79e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—ADCY5—osteoporosis	2.87e-05	5.77e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PTHLH—osteoporosis	2.87e-05	5.77e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PTHLH—osteoporosis	2.87e-05	5.77e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—BMP2—osteoporosis	2.87e-05	5.77e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—BMP2—osteoporosis	2.87e-05	5.77e-05	CbGpPWpGaD
Bepridil—PDE1B—Disease—MYC—osteoporosis	2.84e-05	5.72e-05	CbGpPWpGaD
Bepridil—PDE1B—Disease—TGFB1—osteoporosis	2.84e-05	5.7e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—FGB—osteoporosis	2.81e-05	5.64e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—FGB—osteoporosis	2.81e-05	5.64e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PSMA2—osteoporosis	2.8e-05	5.63e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PSMA5—osteoporosis	2.8e-05	5.63e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—AGER—osteoporosis	2.79e-05	5.6e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—AGER—osteoporosis	2.79e-05	5.6e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—ADCY5—osteoporosis	2.78e-05	5.58e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—ADCY5—osteoporosis	2.78e-05	5.58e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—IL6—osteoporosis	2.77e-05	5.57e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by NGF—IL6—osteoporosis	2.76e-05	5.55e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—CYP19A1—osteoporosis	2.72e-05	5.46e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PSMA2—osteoporosis	2.71e-05	5.45e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PSMA2—osteoporosis	2.71e-05	5.45e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PSMA5—osteoporosis	2.71e-05	5.45e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PSMA5—osteoporosis	2.71e-05	5.45e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by NGF—IL6—osteoporosis	2.67e-05	5.37e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by NGF—IL6—osteoporosis	2.67e-05	5.37e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—ADCY5—osteoporosis	2.65e-05	5.33e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—CYP19A1—osteoporosis	2.63e-05	5.28e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—CYP19A1—osteoporosis	2.63e-05	5.28e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CALCA—osteoporosis	2.61e-05	5.25e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—ENO1—osteoporosis	2.58e-05	5.18e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—ADCY5—osteoporosis	2.56e-05	5.16e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—ADCY5—osteoporosis	2.56e-05	5.16e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PSMA2—osteoporosis	2.54e-05	5.1e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PSMA5—osteoporosis	2.54e-05	5.1e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—IL6—osteoporosis	2.53e-05	5.09e-05	CbGpPWpGaD
Bepridil—PDE1A—Immune System—IL6—osteoporosis	2.53e-05	5.09e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CALCA—osteoporosis	2.52e-05	5.08e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CALCA—osteoporosis	2.52e-05	5.08e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—IRS2—osteoporosis	2.51e-05	5.05e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—MTHFR—osteoporosis	2.44e-05	4.9e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—IRS2—osteoporosis	2.43e-05	4.89e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—IRS2—osteoporosis	2.43e-05	4.89e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—ENO1—osteoporosis	2.43e-05	4.88e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PSMA2—osteoporosis	2.39e-05	4.81e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PSMA5—osteoporosis	2.39e-05	4.81e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—KL—osteoporosis	2.37e-05	4.76e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—MTHFR—osteoporosis	2.36e-05	4.74e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—MTHFR—osteoporosis	2.36e-05	4.74e-05	CbGpPWpGaD
Bepridil—PDE1A—Disease—IL6—osteoporosis	2.34e-05	4.7e-05	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—TGFB1—osteoporosis	2.32e-05	4.67e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—IRS2—osteoporosis	2.32e-05	4.66e-05	CbGpPWpGaD
Bepridil—PDE1B—Immune System—IL6—osteoporosis	2.31e-05	4.65e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—POMC—osteoporosis	2.31e-05	4.65e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—KL—osteoporosis	2.29e-05	4.61e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—KL—osteoporosis	2.29e-05	4.61e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—IL6R—osteoporosis	2.25e-05	4.53e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—TGFB1—osteoporosis	2.25e-05	4.52e-05	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—TGFB1—osteoporosis	2.25e-05	4.52e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—IRS2—osteoporosis	2.24e-05	4.51e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—IRS2—osteoporosis	2.24e-05	4.51e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—POMC—osteoporosis	2.24e-05	4.5e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—POMC—osteoporosis	2.24e-05	4.5e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—ADCY5—osteoporosis	2.22e-05	4.46e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—GPX1—osteoporosis	2.21e-05	4.45e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—IRS1—osteoporosis	2.19e-05	4.41e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—IL6R—osteoporosis	2.18e-05	4.39e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—IL6R—osteoporosis	2.18e-05	4.39e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—MYC—osteoporosis	2.18e-05	4.38e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—TGFB1—osteoporosis	2.17e-05	4.37e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—ADCY5—osteoporosis	2.15e-05	4.32e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—ADCY5—osteoporosis	2.15e-05	4.32e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—GPX1—osteoporosis	2.14e-05	4.3e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—GPX1—osteoporosis	2.14e-05	4.3e-05	CbGpPWpGaD
Bepridil—PDE1B—Disease—IL6—osteoporosis	2.14e-05	4.3e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—IRS1—osteoporosis	2.12e-05	4.27e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—IRS1—osteoporosis	2.12e-05	4.27e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL6R—osteoporosis	2.06e-05	4.14e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CYP19A1—osteoporosis	2.06e-05	4.14e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—MTHFR—osteoporosis	2.04e-05	4.11e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—IRS1—osteoporosis	2.02e-05	4.07e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL6R—osteoporosis	1.99e-05	4.01e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL6R—osteoporosis	1.99e-05	4.01e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—MYC—osteoporosis	1.99e-05	4e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—TGFB1—osteoporosis	1.99e-05	3.99e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—MTHFR—osteoporosis	1.98e-05	3.97e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—MTHFR—osteoporosis	1.98e-05	3.97e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—IRS1—osteoporosis	1.96e-05	3.94e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—IRS1—osteoporosis	1.96e-05	3.94e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.94e-05	3.9e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—IL6R—osteoporosis	1.9e-05	3.82e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—ADCY5—osteoporosis	1.86e-05	3.73e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—IL6R—osteoporosis	1.84e-05	3.7e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—IL6R—osteoporosis	1.84e-05	3.7e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—SPP1—osteoporosis	1.8e-05	3.61e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—ADCY5—osteoporosis	1.8e-05	3.61e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—ADCY5—osteoporosis	1.8e-05	3.61e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—SPP1—osteoporosis	1.74e-05	3.49e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—SPP1—osteoporosis	1.74e-05	3.49e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—ADCY5—osteoporosis	1.68e-05	3.38e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GPX1—osteoporosis	1.68e-05	3.37e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—IL6—osteoporosis	1.64e-05	3.29e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—POMC—osteoporosis	1.63e-05	3.28e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IRS2—osteoporosis	1.62e-05	3.27e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—LEP—osteoporosis	1.59e-05	3.2e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—ADCY5—osteoporosis	1.59e-05	3.19e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GPX1—osteoporosis	1.58e-05	3.18e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—POMC—osteoporosis	1.58e-05	3.18e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—POMC—osteoporosis	1.58e-05	3.18e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—IL6—osteoporosis	1.58e-05	3.17e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IRS2—osteoporosis	1.57e-05	3.16e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IRS2—osteoporosis	1.57e-05	3.16e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL1B—osteoporosis	1.57e-05	3.15e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—MTHFR—osteoporosis	1.55e-05	3.11e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—LEP—osteoporosis	1.54e-05	3.09e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—LEP—osteoporosis	1.54e-05	3.09e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—IL6—osteoporosis	1.52e-05	3.06e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—IL6—osteoporosis	1.52e-05	3.06e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—ESR1—osteoporosis	1.52e-05	3.05e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL1B—osteoporosis	1.52e-05	3.05e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL1B—osteoporosis	1.52e-05	3.05e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—IL6—osteoporosis	1.5e-05	3.01e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—ESR1—osteoporosis	1.47e-05	2.95e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—ESR1—osteoporosis	1.47e-05	2.95e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—MTHFR—osteoporosis	1.46e-05	2.93e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IRS1—osteoporosis	1.42e-05	2.85e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IRS1—osteoporosis	1.37e-05	2.76e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IRS1—osteoporosis	1.37e-05	2.76e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—POMC—osteoporosis	1.37e-05	2.75e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL6R—osteoporosis	1.33e-05	2.68e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—POMC—osteoporosis	1.32e-05	2.66e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—POMC—osteoporosis	1.32e-05	2.66e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IGF1—osteoporosis	1.31e-05	2.64e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL6R—osteoporosis	1.29e-05	2.59e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL6R—osteoporosis	1.29e-05	2.59e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IGF1—osteoporosis	1.27e-05	2.55e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IGF1—osteoporosis	1.27e-05	2.55e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—POMC—osteoporosis	1.24e-05	2.49e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—POMC—osteoporosis	1.17e-05	2.34e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—MYC—osteoporosis	1.13e-05	2.27e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—TGFB1—osteoporosis	1.12e-05	2.26e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—MYC—osteoporosis	1.09e-05	2.19e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—MYC—osteoporosis	1.09e-05	2.19e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—TGFB1—osteoporosis	1.09e-05	2.19e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—TGFB1—osteoporosis	1.09e-05	2.19e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—IL6—osteoporosis	1e-05	2.02e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—IL6—osteoporosis	9.72e-06	1.95e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—IL6—osteoporosis	9.72e-06	1.95e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL6—osteoporosis	9.18e-06	1.85e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL6—osteoporosis	8.88e-06	1.78e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL6—osteoporosis	8.88e-06	1.78e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—IL6—osteoporosis	8.47e-06	1.7e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—IL6—osteoporosis	8.2e-06	1.65e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—IL6—osteoporosis	8.2e-06	1.65e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MYC—osteoporosis	7.89e-06	1.59e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TGFB1—osteoporosis	7.87e-06	1.58e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MYC—osteoporosis	7.63e-06	1.54e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MYC—osteoporosis	7.63e-06	1.54e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TGFB1—osteoporosis	7.62e-06	1.53e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TGFB1—osteoporosis	7.62e-06	1.53e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL6—osteoporosis	5.93e-06	1.19e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL6—osteoporosis	5.74e-06	1.15e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL6—osteoporosis	5.74e-06	1.15e-05	CbGpPWpGaD
